Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Jul 13, 2019 7:34pm
70 Views
Post# 29917478

RE:RE:RE:55% Control LOST.....

RE:RE:RE:55% Control LOST.....
skier59 wrote: Worst case....are you nuts....best case for Mackie and Friends...control of all of our work for a meer $30 million.....you guys are Idiots if any of you think this is a deal anywhere under $1/share....otherwise we walk and talk. give me 2 months, this deal will look like a fart.


Quattro74 wrote:
Skiier, you are correct about the math, I do think you are suggesting a worst case. My guess, we only do the US FDA phase 2 piece, so half what you said. Maybe the price isn't .35c hmm more like .40c? Considering where we've been trading that would be more fair/likely. 

Is someone going to buy 55% of the company? One person or entity? If so I hope they don't screw us. Seriously though, this is setup to sell mostly to rich Canadians, a bit here a bit there. I doubt someone will end up with controlling interest.




It's really too damn hard for the pimp management who has the Stockholm syndrome and people with shoe-sized I.Q to understand that.....
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities